ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Living Kidney Donor Pharmaceutical Care Needs Identified Through Linked Transplant Registry and Pharmacy Claims Data.

K. Lentine,1 S. Gustafson,2 M. Schnitzler,1 G. Hess,3 D. Segev,4 A. Garg,5 N. Lam,6 D. Axelrod,7 D. Brennan,8 H. Randall,1 B. Kasiske.9

1St Louis Univ, St Louis, MO
2SRTR, Minneapolis, MN
3Symphony Health, Philadelphia, PA
4Johns Hopkins, Baltimore, MD
5Western Univ, London, Canada
6Univ Alberta, Edmonton, AB, Canada
7E Carolina Univ, Greenville, NC
8Washington Univ, St. Louis, MO

Meeting: 2017 American Transplant Congress

Abstract number: 377

Keywords: Donation, Kidney, Outcome, Post-operative complications

Session Information

Session Name: Concurrent Session: Logistic and Programatic Challenges in Kidney Living Donation

Session Type: Concurrent Session

Date: Monday, May 1, 2017

Session Time: 4:30pm-6:00pm

 Presentation Time: 5:18pm-5:30pm

Location: E450b

Limited data are available on pharmaceutical care needs of living kidney donors (LKD).

We integrated 1) national US Scientific Registry of Transplant Recipients data for LKD (1987-2012) with 2) pharmacy fill records from a nationwide pharmacy claims warehouse to examine utilization patterns of diabetes treatments, antihypertensive medications, and antidepressants as measures of these conditions before and after donation.

The linked data captured 32,065 LKD actively filling in the first year before, and 36,597 actively filling in the first year after donation (Table 1). A very small but surprising fraction of LKD were treated with insulin or an oral hypoglycemic agent in the 3 years prior to donation. In the first decade following donation, 0.4% received insulin and 2.3% received an oral glucose-lowering agent. Angiotensin converting enzyme inhibitors comprised the most common class of antihypertensive agent used in the years after donation, with use in 11.3% by year 10. Among the sample, 8.6% received a diuretic by year 10. The most common antidepressant prescriptions filled before and after donation were selective serotonin reuptake inhibitors (SSRI). 9.3% of LKD filled an SSRI prescription in the year before donation, and 8.7% in the year after donation.Use of antihypertensive and diabetes medications increase over time after live kidney donation, while antidepressant use appears stable. These data demonstrate the rich potential for linked transplant registry data and pharmacy claims data to examine the incidence and prevalence of medically-treated conditions before and after donation. Future work should compare pharmaceutical care needs of living donors to that of controls with similar baseline good health.

CITATION INFORMATION: Lentine K, Gustafson S, Schnitzler M, Hess G, Segev D, Garg A, Lam N, Axelrod D, Brennan D, Randall H, Kasiske B. Living Kidney Donor Pharmaceutical Care Needs Identified Through Linked Transplant Registry and Pharmacy Claims Data. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Lentine K, Gustafson S, Schnitzler M, Hess G, Segev D, Garg A, Lam N, Axelrod D, Brennan D, Randall H, Kasiske B. Living Kidney Donor Pharmaceutical Care Needs Identified Through Linked Transplant Registry and Pharmacy Claims Data. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/living-kidney-donor-pharmaceutical-care-needs-identified-through-linked-transplant-registry-and-pharmacy-claims-data/. Accessed May 25, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences